Kariya, Japan

Eiichi Mano


Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Kariya, JP (1987 - 1991)
  • Fukaya, JP (2000)

Company Filing History:


Years Active: 1987-2000

Loading Chart...
7 patents (USPTO):

Title: Eiichi Mano: Innovator in Pharmaceutical Chemistry

Introduction

Eiichi Mano is a distinguished inventor based in Kariya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on innovative processes and compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is an oxidation process using TEMPO. This invention relates to an oxidation using sodium chlorite in the presence of a catalytic amount of TEMPO and sodium hypochlorite. It converts the penultimate intermediate bearing a primary alcohol to the target endothelin antagonist compound of Formula I, which has a carboxylic acid. Another notable patent involves crystalline cephalosporin compounds. This invention pertains to stable crystalline compounds and a process for their production, which are useful for the synthesis of desired pharmaceutical products.

Career Highlights

Eiichi Mano has worked with prominent companies in the pharmaceutical industry, including Banyu Pharmaceutical Co. Ltd and Merck & Co., Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Throughout his career, Eiichi Mano has collaborated with notable colleagues such as Susumu Nakagawa and Ryosuke Ushijima. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Eiichi Mano's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…